IQVIA Holdings Inc. (IQV) FCF Payout Ratio: N/A
The FCF payout ratio for IQVIA Holdings Inc. (IQV) is N/A.
IQV FCF Payout Ratio Chart
IQV Average FCF Payout Ratio Chart
IQV FCF Payout Ratio Metrics
FCF PAYOUT RATIO
N/A
FCF PAYOUT RATIO AVG TTM
276.46%
FCF PAYOUT RATIO AVG 3Y
191.85%
FCF PAYOUT RATIO AVG 5Y
191.85%
FCF PAYOUT RATIO AVG 10Y
191.85%
FCF PAYOUT RATIO AVG 15Y
191.85%
FCF PAYOUT RATIO AVG 20Y
191.85%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Payout Ratio Comparison
FCF Payout Ratio
N/A
Earnings Payout Ratio
N/A
Dividend Yield
N/A
FCF Yield
8.45%
Annual FCF Payout Ratio History
| Year | Free Cash Flow | Dividends Paid | FCF Payout Ratio |
|---|---|---|---|
| 2025 | $2.05B | $0 | 0.0% |
| 2024 | $2.11B | $0 | 0.0% |
| 2023 | $1.50B | $0 | 0.0% |
| 2022 | $1.59B | $0 | 0.0% |
| 2021 | $2.30B | $0 | 0.0% |
| 2020 | $1.34B | $0 | 0.0% |
| 2019 | $835.00M | $0 | 0.0% |
| 2018 | $795.00M | $0 | 0.0% |
| 2017 | $601.00M | $0 | 0.0% |
| 2016 | $696.00M | $0 | 0.0% |
| 2015 | $397.30M | $0 | 0.0% |
| 2014 | $349.10M | $0 | 0.0% |
| 2013 | $305.02M | $0 | 0.0% |
| 2012 | $264.37M | $567.85M | 214.8% |
| 2011 | $85.27M | $288.32M | 338.1% |
| 2010 | $297.92M | $67.49M | 22.7% |
Formula: FCF Payout Ratio = Dividends Paid / Free Cash Flow × 100
FCF payout and earnings payout:
- FCF represents operating cash flow after capital expenditures
- FCF payout compares dividends paid with free cash flow
- FCF payout above 100% means dividends paid exceeded free cash flow for the period
- Earnings payout compares dividends paid with net income
Reading the series: Use the chart and table to compare dividend payments with cash generation over time.
IQVIA Holdings Inc. FCF Payout Ratio Formula & Definition
FCF Payout Ratio measures what percentage of free cash flow is paid out as dividends. Unlike earnings-based payout, it compares dividends with cash generated after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IQVIA Holdings Inc. FCF Payout Ratio FAQ
- What is the FCF payout ratio for IQVIA Holdings Inc. (IQV)?
- The FCF payout ratio for IQV stock is N/A.
- What is the TTM average FCF payout ratio for IQVIA Holdings Inc. (IQV)?
- The TTM average FCF payout ratio for IQV stock is 276.46%.
- What is the 3Y average FCF payout ratio for IQVIA Holdings Inc. (IQV)?
- The 3Y average FCF payout ratio for IQV stock is 191.85%.
- What is the 5Y average FCF payout ratio for IQVIA Holdings Inc. (IQV)?
- The 5Y average FCF payout ratio for IQV stock is 191.85%.
- What is the 10Y average FCF payout ratio for IQVIA Holdings Inc. (IQV)?
- The 10Y average FCF payout ratio for IQV stock is 191.85%.
- What is the 15Y average FCF payout ratio for IQVIA Holdings Inc. (IQV)?
- The 15Y average FCF payout ratio for IQV stock is 191.85%.
- What is the 20Y average FCF payout ratio for IQVIA Holdings Inc. (IQV)?
- The 20Y average FCF payout ratio for IQV stock is 191.85%.
IQVIA Holdings Inc. FCF Payout Ratio History
| DATE | FCF PAYOUT RATIO |
|---|---|
| 2012-12-31 | 214.80% |
| 2011-12-31 | 338.11% |
| 2010-12-31 | 22.65% |
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ari Bousbib